Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × cobimetinib × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

INDUSTRY 26 OTHER 6 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Radiotherapy 188 Cisplatin 161 Cyclophosphamide 144 Doxorubicin 113 Paclitaxel 110 Vincristine 103 Filgrastim 98 Carboplatin 89 Etoposide 87 Methotrexate 71 Gemcitabine 71 Docetaxel 67 Fluorouracil 66 Gene Expression Profiling 65 Cytarabine 64 Prednisone 61 Dexamethasone 59 Granulocyte Colony-Stimulating Factor 53 Leucovorin 52 Polymerase Chain Reaction 40 Immunohistochemistry 40 Microarray Analysis 38 Ifosfamide 33 Daunorubicin 33 Irinotecan 32 Temozolomide 31 Amplified Fragment Length Polymorphism Analysis 29 Cetuximab 28 Capecitabine 28 Flow Cytometry 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡